Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Françoise Izar
Observed names:
F Izar,
F. Izar,
Francoise Izar
Institution:
Institut universitaire du cancer de Toulouse Oncopole
Observed institutions:
Tel Aviv Sourasky Medical Center,
Jewish General Hospital,
Institut universitaire du cancer de Toulouse Oncopole
ORCID:
0009-0007-2465-7970
Observed ORCID:
0009-0007-2465-7970
OpenAlex ID:
A5057438353
Total body irradiation using Helical Tomotherapy®: Treatment technique, dosimetric results and initial clinical experience
2018
·
V. Sarradin
, L. Simon
, et al.
·
Cancer/Radiothérapie
·
50
Virtual bolus for total body irradiation treated with helical tomotherapy
2015
·
Gilles Moliner
, Françoise Izar
, et al.
·
Journal of Applied Clinical Medical Physics
·
31
PDF
A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned
2023
·
Berthe M.P. Aleman
, Umberto Ricardi
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
7
PDF
Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/lysa/fil H10 Trial on Stages I/ii Hodgkin Lymphoma
2019
·
B.M. Aleman
, U. Ricardi
, et al.
·
Hematological Oncology
·
2
[Role and results of radiotherapy in the treatment of pancreatic adenocarcinoma].
1990
·
N J Daly
, F Izar
, et al.
·
PubMed
·
2
Initial Outcome of The TARGIT-B International Randomised Trial Of Targeted Intraoperative Radiotherapy Tumour Bed Boost For Young Or High-Risk Patients with Breast Cancer
2026
·
Jayant Vaidya
, Max Bulsara
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
3629 Tolerance of adjuvant radiotherapy after neoadjuvant chemo-immunotherapy for triple-negative breast cancer and impact of the immunotherapy regimen.
2025
·
Ludovic Hernandez
, Tamasine Khadrouche
, et al.
·
Radiotherapy and Oncology
Abstract P2-18-06: Value of PAM50 risk of recurrence score in patients with HR positive HER2 negative early breast cancer and intermediate risk: A single cancer center institution prospective observational study
2020
·
Vincent Nicolaï
, Julia Gilhodes
, et al.
·
Cancer Research
Chimioradiothérapie exclusive avec modulation d’intensité et escalade de dose pour les tumeurs non résécables de l’œsophage : résultats à long terme d’efficacité et de tolérance sur 51 patients
2017
·
A. Modesto
, C. Dalmasso
, et al.
·
Cancer/Radiothérapie
P21. Treatment planning for liver stereotactic body radiation therapy using FFF photon beams
2016
·
S. Ochoa
, L. Simon
, et al.
·
Physica Medica
Champ de tomothérapie : un site révélateur de la mastocytose systémique
2016
·
C. Bulai-Livideanu
, V. Sibaud
, et al.
·
Annales de Dermatologie et de Vénéréologie
EP-1675: Total body irradiation with Tomotherapy
2016
·
L. Simon
, F. Izar
, et al.
·
Radiotherapy and Oncology
PDF
EP-1828: Liver SBRT: benefits from breath-triggered MRI in treatment position for accurate lesion contouring
2016
·
L. Parent
, A. Tournier
, et al.
·
Radiotherapy and Oncology
PDF
111. Récidives ganglionnaires après radiothérapie adjuvante dans le cancer du sein : topographie, dose initiale et impact des nouvelles recommandations de contourage
2013
·
N. Aoulad
, A. Modesto
, et al.
37. Impact du repositionnement sur la délivrance de la dose en tomothérapie pour les cancers du sein gauche avec irradiation ganglionnaire
2013
·
François Picaud
, G. Hangard
, et al.
Show more works
View as search
Works count:
15
Citation count:
92
H-index:
3
I10-index:
2
Year
Topic
Type